Skip to main content
Premium Trial:

Request an Annual Quote

Applied Imaging Shareholders OK Acquisition by Genetix

NEW YORK (GenomeWeb News) — Applied Imaging shareholders have approved the sale of the company to Genetix Group, AI said today.
 
As GenomeWeb News reported when the acquisition was announced in September, the all-cash deal is valued at $25.8 million. Genetix will pay $4.20 for each share of Applied Imaging's common stock.
 
Since announcing the deal, Genetix has raised its original bid price of $3.03 several times in response to unsolicited bids by at least one third-party to purchase Applied Imaging.
 
The companies did not say when they expect the deal to close.

This article originally appeared in ProteoMonitor, a GenomeWeb News sister publication.
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.